These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

375 related items for PubMed ID: 3093302

  • 1. Effect of aldose reductase inhibitor (sorbinil) on integration of polyol pathway, pentose phosphate pathway, and glycolytic route in diabetic rat lens.
    Gonzalez AM, Sochor M, Hothersall JS, McLean P.
    Diabetes; 1986 Nov; 35(11):1200-5. PubMed ID: 3093302
    [Abstract] [Full Text] [Related]

  • 2. The effect of an aldose reductase inhibitor (Sorbinil) on the level of metabolites in lenses of diabetic rats.
    Gonzalez AM, Sochor M, McLean P.
    Diabetes; 1983 May; 32(5):482-5. PubMed ID: 6404681
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of an aldose reductase inhibitor on lens metabolism, ATPases and antioxidative defense in streptozotocin-diabetic rats: an intervention study.
    Obrosova IG, Fathallah L.
    Diabetologia; 2000 Aug; 43(8):1048-55. PubMed ID: 10990083
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the effects of Zopolrestat and Sorbinil on lens myo-inositol influx.
    Beyer-Mears A, Diecke FP, Mistry K, Cruz E.
    Pharmacology; 1997 Feb; 54(2):76-83. PubMed ID: 9088040
    [Abstract] [Full Text] [Related]

  • 5. Glycolytic pathway, redox state of NAD(P)-couples and energy metabolism in lens in galactose-fed rats: effect of an aldose reductase inhibitor.
    Obrosova I, Faller A, Burgan J, Ostrow E, Williamson JR.
    Curr Eye Res; 1997 Jan; 16(1):34-43. PubMed ID: 9043821
    [Abstract] [Full Text] [Related]

  • 6. The effect of high glucose and oxidative stress on lens metabolism, aldose reductase, and senile cataractogenesis.
    Cheng HM, González RG.
    Metabolism; 1986 Apr; 35(4 Suppl 1):10-4. PubMed ID: 3083198
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. CP-45,634: a novel aldose reductase inhibitor that inhibits polyol pathway activity in diabetic and galactosemic rats.
    Peterson MJ, Sarges R, Aldinger CE, MacDonald DP.
    Metabolism; 1979 Apr; 28(4 Suppl 1):456-61. PubMed ID: 122297
    [Abstract] [Full Text] [Related]

  • 9. Effects of the aldose reductase inhibitor sorbinil on the isolated cultured rat lens.
    Yeh LA, Rafford CE, Beyer TA, Hutson NJ.
    Metabolism; 1986 Apr; 35(4 Suppl 1):4-9. PubMed ID: 3083208
    [Abstract] [Full Text] [Related]

  • 10. Nonosmotic diabetic cataracts.
    Malone JI, Lowitt S, Cook WR.
    Pediatr Res; 1990 Mar; 27(3):293-6. PubMed ID: 2138728
    [Abstract] [Full Text] [Related]

  • 11. Reversal of diabetic cataract by sorbinil, an aldose reductase inhibitor.
    Beyer-Mears A, Cruz E.
    Diabetes; 1985 Jan; 34(1):15-21. PubMed ID: 3917257
    [Abstract] [Full Text] [Related]

  • 12. Na+-K+-ATPase pumping activity is not directly linked to myo-inositol levels after sorbinil treatment in lenses of diabetic rats.
    Yeh LA, Rafford CE, Goddu KJ, Ashton MA, Beyer TA, Hutson NJ.
    Diabetes; 1987 Dec; 36(12):1414-9. PubMed ID: 2824260
    [Abstract] [Full Text] [Related]

  • 13. Effects of aldose reductase inhibitor sorbinil on neuroaxonal dystrophy and levels of myo-inositol and sorbitol in sympathetic autonomic ganglia of streptozocin-induced diabetic rats.
    Schmidt RE, Plurad SB, Sherman WR, Williamson JR, Tilton RG.
    Diabetes; 1989 May; 38(5):569-79. PubMed ID: 2497038
    [Abstract] [Full Text] [Related]

  • 14. Activation of aldose reductase from human tissues.
    Das B, Srivastava SK.
    Diabetes; 1985 Nov; 34(11):1145-51. PubMed ID: 3930326
    [Abstract] [Full Text] [Related]

  • 15. Increased nerve polyol levels in experimental diabetes and their reversal by Sorbinil.
    Whiting PH, Ross IS.
    Br J Exp Pathol; 1988 Oct; 69(5):697-702. PubMed ID: 3143396
    [Abstract] [Full Text] [Related]

  • 16. Sorbinil suppresses glomerular prostaglandin production in the streptozotocin diabetic rat.
    Craven PA, DeRubertis FR.
    Metabolism; 1989 Jul; 38(7):649-54. PubMed ID: 2500578
    [Abstract] [Full Text] [Related]

  • 17. Diabetic complications in lens and nerve and their prevention by sulindac or sorbinil: two novel aldose reductase inhibitors.
    Jacobson M, Sharma YR, Cotlier E, Hollander JD.
    Invest Ophthalmol Vis Sci; 1983 Oct; 24(10):1426-9. PubMed ID: 6413448
    [Abstract] [Full Text] [Related]

  • 18. Sorbinil prevents glomerular hyperperfusion in diabetic rats.
    Bank N, Mower P, Aynedjian HS, Wilkes BM, Silverman S.
    Am J Physiol; 1989 Jun; 256(6 Pt 2):F1000-6. PubMed ID: 2500028
    [Abstract] [Full Text] [Related]

  • 19. The penetration of Sorbinil, an aldose reductase inhibitor, into lens, aqueous humour and erythrocytes of patients undergoing cataract extraction.
    Crabbe MJ, Petchey M, Burgess SE, Cheng H.
    Exp Eye Res; 1985 Jan; 40(1):95-9. PubMed ID: 3920064
    [Abstract] [Full Text] [Related]

  • 20. Sorbinil protection of lens protein components and cell hydration during diabetic cataract formation.
    Beyer-Mears A, Cruz E, Nicolas-Alexandre J, Varagiannis E.
    Pharmacology; 1982 Jan; 24(3):193-200. PubMed ID: 6803262
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.